Search Prime Grants

2433137

Project Grant

Overview

Grant Description
SBIR Phase I: AI-powered low-dose, low-cost, high-quality CT imaging - The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project stem from the development of methods to display and diagnose heart rhythms more accurately and continuously after cardiac surgery.

Inadequate post-operative rhythm monitoring remains a significant concern in over 400,000 cardiac surgeries in the United States (US), 30-50% of which result in arrhythmias.

Arrhythmias, especially when missed or diagnosed late due to inaccurate or delayed monitoring, often lead to worse patient outcomes, including stroke, cardiac dysfunction, heart failure, and death.

These issues are associated with hospital expenses exceeding $9,000 per hospital stay per patient within the growing $8-billion US post-operative cardiac care market.

Beyond the significant economic impact, more accurate and continuous post-operative cardiac rhythm monitoring would provide substantial, potentially lifesaving benefits to human health.

This Small Business Technology Transfer (STTR) Phase I project aims to address the limitations of current post-operative rhythm diagnosis using standard surface-based electrocardiogram (ECG) monitoring.

The inadequacy of atrial signal quality makes it challenging or impossible for providers to interpret rhythm accurately.

Additionally, significant variations in patient and ECG characteristics limit the utility of current rhythm monitoring systems, impacting the optimal care of critically ill patients.

This project will develop and validate a method for continuous rhythm diagnosis and display using the highest quality atrial electrogram.

The diagnosis method will be developed, validated, and optimized with real patient data, ensuring adaptability to varying patient, rhythm, and ECG characteristics.

The anticipated outcome is a shift from the current labor-intensive, non-real-time, and inconveniently displayed methodology, which requires specialized training, to a real-time, more accurate, continuous, and easily accessible diagnosis system.

If successful, this project is expected to substantially improve post-operative care and establish a more accurate standard for post-operative rhythm assessment.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.

Subawards are planned for this award.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE I", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF23515
Awarding / Funding Agency
Place of Performance
Los Altos, California 94022-3911 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 7% from $275,000 to $295,000.
Neuraltrak was awarded Project Grant 2433137 worth $295,000 from National Science Foundation in September 2024 with work to be completed primarily in Los Altos California United States. The grant has a duration of 1 year and was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships. The Project Grant was awarded through grant opportunity NSF Small Business Innovation Research / Small Business Technology Transfer Phase I Programs.

SBIR Details

Research Type
SBIR Phase I
Title
SBIR Phase I: AI-Powered Low-dose, Low-cost, High-Quality CT imaging
Abstract
The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to enable local (and global) access to high-quality, low-cost, and low-radiation exposure three-dimensional (3D) computed tomography (CT) imaging using existing 2D equipment. Examples include walk-in clinics, lung cancer screening centers, rapid stroke assessment centers, mobile platforms (e.g., ambulances), battlefield hospitals, and clinics in rural and underserved areas. This advance will result in greater public access to advanced healthcare and should result in substantially lower healthcare costs. For example, moving complex spine surgeries from hospitals to local ambulatory surgical centers (ASCs) can save payors $10B in costs annually. The ASCs will also benefit; a relatively low percentage of complex monthly procedures can double their profits. Patient satisfaction should improve by moving more complicated spine surgical procedures to smaller ASCs closer to home with fewer infection risks. The useful life of legacy X-ray systems will be extended following conversion to 3D, thereby reducing waste and landfill space. Beyond medicine, the project technology has widespread applications in nondestructive testing, from manufacturing to failure analysis/prevention to archaeology and art! All these advantages will enhance US competitiveness. This Small Business Innovation Research (SBIR) Phase I project will enable simple, small-footprint, mobile, two-dimensional (2D) X-ray imaging systems to generate three-dimensional (3D) computed tomography (CT) images at low cost, with one-third of the X-ray dose of a conventional CT scan. The project combines recent advances in imaging physics with artificial intelligence (AI) to overcome the limitations of current CT image acquisition. This contrasts with conventional AI-based CT de-noising (image cleaning) algorithms that function only in the image domain with no physics input. The project has three primary research objectives. First, enhance deep learning-based image reconstruction's ability to produce high-quality images from limited data. Second, devise real-time geometric calibration methods to overcome mechanical instabilities inherent to simple X-ray systems. Third, develop high speed and high image fidelity data transfer methods to interface existing hospital imaging systems to the project computing platform while maintaining FDA and HIPPA compliance and avoiding disruption of hospital workflow. Successful development of the three core technologies described will be used to create a minimum viable product (MVP). Medical practitioners will use the MVP to evaluate the technology and refine the features needed for a clinical product. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
BM
Solicitation Number
NSF 23-515

Status
(Ongoing)

Last Modified 8/12/25

Period of Performance
9/1/24
Start Date
8/31/25
End Date
98.0% Complete

Funding Split
$295.0K
Federal Obligation
$0.0
Non-Federal Obligation
$295.0K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to 2433137

Transaction History

Modifications to 2433137

Additional Detail

Award ID FAIN
2433137
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
XHJSFKKWBDU5
Awardee CAGE
None
Performance District
CA-16
Senators
Dianne Feinstein
Alejandro Padilla
Modified: 8/12/25